19,08 €
4,82 %vorgestern
L&S, 1. März, 22:53 Uhr
ISIN
US1638511089
Symbol
CC
Berichte

Chemours Co. Aktie News

Neutral
Accesswire
etwa 15 Stunden alt
NEW YORK, NY / ACCESSWIRE / March 2, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. On February 13, 2024, after the market close, Chemours Co. announced that it would be delaying the release of Q4 and full year 2023 financial results as the Com...
Neutral
Business Wire
etwa 18 Stunden alt
NEW YORK--(BUSINESS WIRE)--Labaton Keller Sucharow, an award-winning shareholder rights firm, is investigating potential violations of the federal securities laws on behalf of investors of The Chemours Company (NYSE: CC) (“Chemours”). Chemours is a global chemical manufacturer headquartered in Wilmington, Delaware. On February 13, 2024, Chemours announced that it would be delaying the release o...
Neutral
Accesswire
2 Tage alt
NEW YORK, NY / ACCESSWIRE / March 1, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. On February 13, 2024, after the market close, Chemours Co. announced that it would be delaying the release of Q4 and full year 2023 financial results as the Com...
Neutral
Business Wire
3 Tage alt
OAKLAND, Calif.--(BUSINESS WIRE)---- $CC #CC--Gibbs Law Group Cruz continues its investigation on behalf of Chemours Company (“Chemours”) (NYSE: CC) investors.
Neutral
Business Wire
3 Tage alt
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz continues its investigation of The Chemours Company (“Chemours” or the “Company”) (NYSE: CC) on behalf of investors concerning the Company's possible violations of federal securities laws. If you are a shareholder who suffered a loss, click here to participate. On February 13, 2024, after the market closed, Chemours disclosed that i...
Negativ
The Motley Fool
3 Tage alt
Chemours delayed issuance of its financial reports for Q4 and 2023 this morning. Management warned that when it does report, it will report a loss.
Neutral
PRNewsWire
3 Tage alt
MILWAUKEE , Feb. 29, 2024 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against Chemours (NYSE: CC). The investigation results from inaccurate statements Chemours may have made regarding its accounting, business operations and prospects.
Neutral
Seeking Alpha
3 Tage alt
Chemours CEO, CFO, and key personnel placed on administrative leave pending internal review. Company discloses potential weaknesses in internal controls, leading to delayed year-end reporting. Chemours experiences a significant decline in stock price, but potential for overreaction and undervaluation. I consider the company interesting, and I will show you why.
Mehr News anzeigen

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen